Showing results (1381-1390 of 1,686) with videos related to

Sort By:
Pageof 169
The American Journal of Cardiology|December 15, 1996
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesM Labinaz, M H Sketch, A L Stebbins, et al.
Circulation|April 15, 1995
Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT InvestigatorsJ E Tcheng, R A Harrington, K Kottke-Marchant, et al.
The American Journal of Cardiology|February 15, 1997
Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial)E G Bovill, R P Tracy, G L Knatterud, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 8, 2012
Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasmaThomas A Lanz, Susan E Bove, Catherine D Pilsmaker, et al.
Journal of Pharmacological and Toxicological Methods|March 30, 2023
Improving the in Vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substituteHugo M Vargas, Eric I Rossman, Todd A Wisialowski, et al.
The New England Journal of Medicine|May 4, 2000
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic EventsW W O'Neill, P Serruys, M Knudtson, et al.
Circulation|July 27, 2001
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary interventionI C Gilchrist, J C O'Shea, T Kosoglou, et al.
Journal of the American College of Cardiology|March 1, 1996
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyD J Kereiakes, N S Kleiman, J Ambrose, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 21, 2018
Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacementAndres M Pineda, J Kevin Harrison, Neal S Kleiman, et al.
Journal of the American College of Cardiology|July 21, 1998
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathyS F Nagueh, N M Lakkis, Z X He, et al.
Pageof 169